Healthcare

H 4042 would allow South Carolinians to purchase ivermectin tablets without a prescription or pharmacist consultation. The bill amends state law to authorize over-the-counter sales of ivermectin tablets, removing current requirements for medical authorization. This change would directly affect consumers seeking to buy ivermectin for personal use, as it eliminates the need for a doctor's order or pharmacy interaction. The bill is currently in committee referral after its introduction on February 19, 2025.

AN ACT TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY AMENDING SECTION 40-43-210, RELATING TO THE DEFINITION OF A "SELF-ADMINISTERED HORMONAL CONTRACEPTIVE" IN THE PHARMACY PRACTICE ACT, SO AS TO REVISE THE DEFINITION; BY AMENDING SECTION 40-43-230, RELATING TO PHARMACISTS PERMITTED TO DISPENSE SELF-ADMINISTERED HORMONAL CONTRACEPTIVES IN CERTAIN CIRCUMSTANCES, SO AS TO PROVIDE SUCH DISPENSATIONS MAY BE MADE PURSUANT TO CERTAIN WRITTEN JOINT PROTOCOLS; AND BY AMENDING SECTION 40-43-240, RELATING TO WRITTEN JOINT PROTOCOLS BY THE BOARD OF MEDICAL EXAMINERS AND THE BOARD OF PHARMACY TO AUTHORIZE PHARMACISTS TO DISPENSE SELF-ADMINISTERED HORMONAL CONTRACEPTIVES WITHOUT PATIENT-SPECIFIC WRITTEN ORDERS, SO AS TO INSTEAD PROVIDE THE DISPENSATIONS MAY BE MADE UNDER STANDING ORDERS OR WITHOUT STANDING ORDERS WHEN DISPENSED OR ADMINISTERED PURSUANT TO CERTAIN WRITTEN JOINT PROTOCOLS. - RATIFIED TITLE

A BILL TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY ADDING CHAPTER 9 TO TITLE 41 SO AS TO PROHIBIT NONCOMPETE CLAUSES IN PHYSICIAN CONTRACTS, TO PROTECT PATIENT FREEDOM OF CHOICE, TO DEFINE IMPERMISSIBLE RESTRICTIONS ON PHYSICIAN PRACTICE, TO ALLOW CERTAIN RECOUPMENT OF EXPENSES AND PROTECTION OF LEGITIMATE BUSINESS INTERESTS, AND TO PROVIDE FOR APPLICABILITY.

A CONCURRENT RESOLUTION TO PROVIDE THAT IN ADDITION TO THE MATTERS WHICH MAY BE CONSIDERED BY THE GENERAL ASSEMBLY AFTER MAY 8, 2025, PURSUANT TO THE SINE DIE RESOLUTION FOR THE 2025 LEGISLATIVE SESSION AS PASSED BY THE GENERAL ASSEMBLY, H. 4262 RELATING TO RESTRICTING, REGULATING, OR PROHIBITING MRNA GENE THERAPIES ALSO MAY BE INTRODUCED, RECEIVED, AND CONSIDERED BY EACH BODY OF THE GENERAL ASSEMBLY PRIOR TO SINE DIE ADJOURNMENT INCLUDING, BUT NOT LIMITED TO, CONCURRENCE, NONCONCURRENCE, AND APPOINTMENT OF CONFEREES; RECEIPT, CONSIDERATION, AND DISPOSITION OF CONFERENCE AND FREE CONFERENCE REPORTS; AND RECEIPT, CONSIDERATION, AND DISPOSITION OF ANY VETOES, IF APPLICABLE.